UNICA IRIS Institutional Research Information System

DE LOGU, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 172.345
NA - Nord America 9.769
AS - Asia 4.664
SA - Sud America 683
AF - Africa 107
Continente sconosciuto - Info sul continente non disponibili 7
Totale 187.575
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 168.699
US - Stati Uniti d'America 9.600
SG - Singapore 1.873
CN - Cina 1.787
UA - Ucraina 1.050
DE - Germania 610
SE - Svezia 602
FI - Finlandia 560
BR - Brasile 504
VN - Vietnam 350
GB - Regno Unito 301
FR - Francia 277
HK - Hong Kong 135
IN - India 117
KR - Corea 113
CA - Canada 86
MX - Messico 67
BD - Bangladesh 51
AR - Argentina 47
MA - Marocco 45
RU - Federazione Russa 44
EC - Ecuador 41
NL - Olanda 40
IQ - Iraq 38
JP - Giappone 27
CO - Colombia 25
TR - Turchia 25
BE - Belgio 22
ES - Italia 22
ID - Indonesia 22
PL - Polonia 22
ZA - Sudafrica 19
PE - Perù 18
PK - Pakistan 18
VE - Venezuela 15
UZ - Uzbekistan 12
CH - Svizzera 11
IE - Irlanda 11
PH - Filippine 11
SA - Arabia Saudita 11
AT - Austria 10
CL - Cile 10
IL - Israele 10
MD - Moldavia 10
PY - Paraguay 10
EG - Egitto 9
KE - Kenya 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
TN - Tunisia 7
AL - Albania 6
EU - Europa 6
JO - Giordania 6
AZ - Azerbaigian 5
BO - Bolivia 5
CR - Costa Rica 5
DZ - Algeria 5
IR - Iran 5
MY - Malesia 5
RO - Romania 5
BY - Bielorussia 4
HU - Ungheria 4
KZ - Kazakistan 4
SM - San Marino 4
TW - Taiwan 4
CZ - Repubblica Ceca 3
DK - Danimarca 3
GE - Georgia 3
LT - Lituania 3
MU - Mauritius 3
OM - Oman 3
PT - Portogallo 3
SI - Slovenia 3
SN - Senegal 3
TH - Thailandia 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CG - Congo 2
CU - Cuba 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NP - Nepal 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BZ - Belize 1
ET - Etiopia 1
Totale 187.563
Salva come PNG Salva come JPEG
Città #
Cagliari 164.153
Uta 3.055
Singapore 856
Chandler 764
Ashburn 747
Woodbridge 634
Fairfield 625
San Jose 610
Jacksonville 597
Boardman 568
Ann Arbor 491
Dallas 451
Houston 406
Nyköping 406
Helsinki 403
Wilmington 327
Beijing 260
Munich 257
Seattle 257
New York 231
Los Angeles 220
Cambridge 214
Hefei 209
Boston 181
Nanjing 162
Lauterbourg 139
Santa Clara 132
Dearborn 125
Hong Kong 122
Ho Chi Minh City 117
Seoul 112
Milan 104
Buffalo 90
The Dalles 86
Shanghai 85
Rome 83
Hanoi 79
Redwood City 68
Shenyang 61
Nanchang 59
Chicago 58
Toronto 58
Tianjin 57
Hebei 49
Verona 48
Changsha 45
São Paulo 44
Guangzhou 36
San Diego 35
Jiaxing 33
Casablanca 30
Council Bluffs 30
Orange 30
Atlanta 29
Chennai 28
London 28
Zhengzhou 28
Jinan 26
Washington 26
Orem 24
Norwalk 23
Ningbo 21
Florence 19
Redondo Beach 19
Tokyo 19
Brussels 18
Bologna 17
Brooklyn 17
Nuremberg 17
Elk Grove Village 16
Rio de Janeiro 16
Frankfurt am Main 15
Quito 15
Sassari 15
Warsaw 15
Auburn Hills 14
Dhaka 14
Genoa 14
Hangzhou 14
Johannesburg 14
Haiphong 13
Mountain View 13
Saint Petersburg 12
Salt Lake City 12
Baghdad 11
Caserta 11
Curitiba 11
Da Nang 11
Jyväskylä 11
Naples 11
Palermo 11
Phoenix 11
Pune 11
San Francisco 11
Turin 11
Turku 11
Amsterdam 10
Catania 10
Cedar Knolls 10
Sìnnai 10
Totale 179.842
Salva come PNG Salva come JPEG
Nome #
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.056
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifabutina, rifampicina e amikacina nei confronti di Mycobacterium avium 4.608
Limonoids from Melia azedarach fruits as inhibitors of flaviviruses and mycobacterium tubercolosis 4.484
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.406
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases 3.497
Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells 3.064
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 2.765
Discovery of in vitro antitubercular agents through in silico ligand-based approaches 2.375
Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1 2.331
Naturally occurring Diels-Alder-type adducts from Morus nigra as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B 2.267
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents. Design, synthesis, biological evaluation and study of their mode of action. 2.247
Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection 2.205
Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach 2.194
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.180
HPLC-DAD-MS analysis and antiviral activity of different extracts and isolated costituents from Bituminaria bituminosa 2.159
Imidazole and 1,2,4-triazole-based derivatives gifted with antitubercular activity: Cytotoxicity and computational assessment 2.109
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 2.104
Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis 2.099
Improving the physical chemical properties of a very promising class of pyrrole antimycobacterial agents 2.048
Antimycobacterial activity of new N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives 2.004
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation 2.000
In vivo potent BM635 analogue with improved drug-like properties 1.979
Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation 1.958
1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis and microbiological evaluation 1.955
null 1.953
null 1.949
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.930
Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones 1.917
The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug 1.917
null 1.829
1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings 1.814
Nuove strategie per lo sviluppo di farmaci antitubercolari: caratterizzazione di target alternativi e di fattori di virulenza in Mycobacterium tuberculosis 1.799
Design, synthesis and antimycobacterial activity of benzoxazinone derivatives and open-ring analogues: Preliminary data and computational analysis 1.792
Sherris. Microbiologia medica 1.771
null 1.749
Individuazione di nuovi target in MDR e XDR Mycobacterium tuberculosis mediante 1,5-difenil- e 1,5-diaril-2-etil-pirroli per lo sviluppo di nuovi agenti antitubercolari 1.684
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.663
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.654
Attività fungicida di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Candida spp. 1.640
Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis 1.613
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.595
Phenazine-1-carboxilyc acid derivatives suppressing the RNA polymerase as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis 1.551
Novel N-aryl- and N-heteryl-phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis 1.548
Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis 1.514
Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin 1.477
Effetto di Inibitori delle COX-1 e COX-2 sullo sviluppo del biofilm di Candida albicans: studio della associazione di FANS e derivati azolici per la profilassi delle infezioni fungine contratte in ambiente ospedaliero 1.472
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.468
Synergistic interaction in vitro between rifabutin and newly synthesized S-alkylisothiosemicarbazones derivatives against mycobacterium avium 1.458
dentification of a new Chemical Class of Potent Antimycobacterial Compounds 1.440
BM 579: a novel pyrrole derivative with improved antimycobacterial activity 1.428
Novel Pyrazole-Containing Compounds Active against Mycobacterium tuberculosis 1.406
Design, synthesis and microbiological characterization of 1,5-diphenyl and 1,5-diaryl-2-ethylpyrrole derivatives as new potential agents of infections sustained by MDR and XDR Mycobacterium tuberculosis. 1.364
Nuovo sistema di fermentazione in semi-solido per la produzione di enzimi cellulosolitici 1.348
Infezioni nosocomiali da Pseudomonas maltophilia in un reparto di terapia intensiva per neonat 1.284
Sul trattamento microbiologico delle acque di vegetazione 1.282
Synergistic interactions in vitro between Rifabutin and newly synthesized s-alkylthiosemicarbazone derivatives against M. avium 1.271
Effetto di FANS sulla formazione di biofilm di Candida albicans e potenziamento della attività di farmaci antifungini 1.241
Saggi e dosaggi microbiologici della Farmacopea 1.234
Studio di un metodo rapido mediante riduzione di XTT per la determinazione della resistenza in Mycobacterium tuberculosis 1.220
BM212 and its derivatives: lead optimization of a new class of antimycobacterial agents. 1.191
Pyrrole derivatives of BM212 as novel antimycobacterial agents Design, synthesis, biological evaluation and study of their mode of action 1.171
null 1.144
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.130
Antimycobacterial Activiy of New 1,4-Benzoxazine-2-one derivatives and its 2-(arylamino)-4-oxobut-2-enoate, ring-open analogues 1.123
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents.Design, synthesis, biological evaluation and study of their mode of action. 1.109
Design and synthesis of 1,5-diaryl-2-ethyl pyrrole derivatives and their evaluation as antimycobacterial agents 1.077
null 1.070
Derivatives of BM 212: synthesis and biological evaluation of new derivatives with improved antimycobacterial activity. 1.041
In vitro antiviral activity of liposomal Artemisia arborescens essential oil 1.040
Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones 1.035
New pyrrole derivatives of BM 212: lead compound optimization strategy, Tuberculosis drug development. Targets, technologies and trials. 999
L’OLIO ESSENZIALE DI ARTEMISIA ARBORESCENS INATTIVA HSV1 E HSV2 E INIBISCE LA DIFFUSIONE LATERALE DI CELLULE VERO 997
Synthesis and antimicrobial activity of novel arylideneisothiosemicarbazones 975
null 935
Attività di un derivato isotiosemicarbazonico ciclico nei confronti di biofilm di Candida albicans FLC-S e FLC-R in combinazione con AMB 910
PHISICAL STABILITY OF ARTEMISIA ARBORESCENS L. ESSENTIAL OIL LOADED SLN AND IN VITRO ANTIVIRAL ACTIVITY 908
Influenza dell'inclusione liposomiale sull'attività in vitro di miconazolo e ketoconazolo 864
null 826
Aumento della sensibilità all’AmB di biofilm di Candida albicans fluconazolo-resistente nell’impiego combinato con derivati ciclici isotiosemicarbazonici 825
null 818
Effetti dei liposomi sull'attività in vitro di alcuni antifungini 805
L’olio essenziale di Artemisia arborescens inattiva HSV-1 e HSV-2 e inibisce la diffusione laterale in cellule Vero 785
Studio dell’attività di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Aspergillus spp 764
null 764
Aspetti Microbiologici della Produzione Farmaceutica 747
null 736
In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium 707
Strategie alternative per la profilassi delle infezioni sostenute da Candida albicans contratte in ambiente ospedaliero mediante isotiosemicarbazoni ciclici 701
Isothiosemicarbazones as alternative approach to the therapy of infections sustained by Candida albicans 688
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis 656
Studio della attività di una nuova classe di isotiosemicarbazoni nei confronti di Aspergillus spp. di isolamento clinico. 655
Degradazione biologica degli aghi di pino (Pinus Silvester) 651
Liposomes as carrier for Artemisia arborescens essential oil: preparation, characterisation and antiviral activity 649
Attività intramacrofagica di nuovi agenti antitubercolari per il trattamento delle infezioni sostenute da ceppi MDR mediante inibizione selettiva della RNA polimerasi. 644
 and  opiate receptors mediate specific behavioral syndromes from the Substantia Nigra. 624
Saggi e dosaggi microbiologici della Farmacopea 610
Aspetti microbiologici della produzione farmaceutica 609
null 605
PHYSICAL STABILITY OF ARTEMISIA ARBORESCENS ESSENTIAL OIL LOADED SLN AND IN VITRO ANTIVIRAL ACTIVITY 586
Stafilococchi 580
Totale 154.123
Salva come PNG Salva come JPEG
Categoria #
all - tutte 240.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 240.981
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.100 0 0 0 0 0 0 0 0 0 2.050 1.688 1.362
2021/20228.886 1.427 908 478 567 715 541 389 529 756 769 902 905
2022/202312.524 1.314 1.647 1.447 886 818 1.183 645 1.462 742 620 954 806
2023/202416.879 940 523 1.037 1.211 1.661 3.247 2.625 943 684 1.201 1.491 1.316
2024/202534.953 7.713 11.595 4.674 2.829 1.715 1.663 2.824 277 451 317 443 452
2025/20268.591 490 699 1.088 1.127 500 599 1.264 1.104 663 1.057 0 0
Totale 187.824